Keebeck Wealth Management’s Amneal Pharmaceuticals AMRX Stock Holding History

Keebeck Wealth Management’s Portfolio AMRX Stock Details AMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-10,000	Closed	-$53K	–	219
2021 Q3	$53K	Hold	10,000	–	–	0.01%	210
2021 Q2	$51K	Hold	10,000	–	–	0.01%	236
2021 Q1	$67K	Hold	10,000	–	–	0.01%	231
2020 Q4	$46K	Hold	10,000	–	–	0.01%	204
2020 Q3	$38K	Hold	10,000	–	–	0.01%	181
2020 Q2	$47K	Buy	+10,000	New	+$41.2K	0.01%	222

Other funds holding AMRX

Fosun International Hong Kong, China $446M AUM 13.33% 1-Year Est. Return

TGA

TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Keebeck Wealth Management's AMRX Position: Q4 2021 in Review

Keebeck Wealth Management sold out of Amneal Pharmaceuticals (AMRX) in Q4 2021, closing a stake of 10,000 shares — an estimated $53K sold.

Keebeck Wealth Management first reported a position in AMRX in Q2 2020 and held it in 6 quarters. The position peaked at $67K in Q1 2021. 154 funds tracked by Wall St. Rank hold AMRX as of Q4 2021.

Keebeck Wealth Management reported no remaining Amneal Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
Keebeck Wealth Management sold 10,000 Amneal Pharmaceuticals shares in Q4 2021, an estimated $53K.
Keebeck Wealth Management first reported a position in Amneal Pharmaceuticals in Q2 2020 and held it in 6 quarters.
Keebeck Wealth Management's Amneal Pharmaceuticals position peaked at $67K in Q1 2021.
154 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q4 2021.

Based on Keebeck Wealth Management's 13F filing for Q4 2021, filed 14 Feb 2022.